Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series. Moccia M, Buonomo AR, Scotto R, Viceconte G, et al. J Neurol Sci 2022;439:120306.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moccia M, Buonomo AR, Scotto R, Viceconte G, et al. Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series. J Neurol Sci 2022;439:120306.
PMID: 35689866